Volitionrx (VNRX) Shareholder's Equity Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42.90% |
| Sep 30, 2025 | -58.79% |
| Jun 30, 2025 | -44.55% |
| Mar 31, 2025 | -74.65% |
| Dec 31, 2024 | -185.89% |
| Sep 30, 2024 | -694.03% |
| Jun 30, 2024 | -547.38% |
| Mar 31, 2024 | -457.51% |
| Dec 31, 2023 | -178.62% |
| Sep 30, 2023 | -200.40% |
| Jun 30, 2023 | 25.47% |
| Mar 31, 2023 | -127.58% |
| Dec 31, 2022 | -117.64% |
| Sep 30, 2022 | -86.59% |
| Jun 30, 2022 | -84.68% |
| Mar 31, 2022 | -65.31% |
| Dec 31, 2021 | 8.77% |
| Sep 30, 2021 | 11.70% |
| Jun 30, 2021 | 42.68% |
| Mar 31, 2021 | 239.27% |
| Dec 31, 2020 | 14.76% |
| Sep 30, 2020 | 6.51% |
| Jun 30, 2020 | 13.92% |
| Mar 31, 2020 | -39.21% |
| Dec 31, 2019 | 16.95% |
| Sep 30, 2019 | 17.83% |
| Jun 30, 2019 | 63.03% |
| Mar 31, 2019 | 7.83% |
| Dec 31, 2018 | 21.92% |
| Jun 30, 2013 | -43.90% |
| Mar 31, 2013 | -28.79% |
| Dec 31, 2012 | -23.43% |